Anosmia News and Research

RSS

Researchers conduct large meta-analysis of COVID-19’s neurological manifestations

The global spread of the COVID-19 pandemic, caused by SARS-CoV-2, has led to intense interest in the various manifestations of the infection, including its neurological features. A compact summation by researchers across the UK of what is known at present about this facet of the disease is presented in a new paper.

3 Mar 2021

Researchers examine long-term immune responses following COVID-19 across clinically diverse cohort

A new study by researchers at the University of California, San Francisco, discusses the different aspects of long-term immune responses in a wide sample of patients, as well as how they vary in clinical severity and sequelae.

3 Mar 2021

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

The study, published in the pre-print server medRxiv, demonstrates the presence of long-lasting neuropsychological sequelae after COVID-19, regardless of the respiratory disease's severity.

2 Mar 2021

Study finds link between Googling symptoms and COVID-19 cases

Yasser El-Manzalawy and colleagues from Geisinger sought to find patterns with Google searches that could predict coronavirus spread. Based on Google search trends for nine symptoms, the team suggests their model can estimate the number of COVID-19 cases across the United States up to three weeks ahead.

25 Feb 2021

Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain

A new study describes the results of a macaque study that showed the development of neurological features of inflammation, following infection by SARS-CoV-2.

25 Feb 2021

Household odorant smell tests could help detect COVID-19, say study

Researchers at the Weizmann Institute of Science and other institutions developed a new tool to help detect COVID-19 infection. The team developed and tested a real-time tool to measure olfactory perception impairment by asking the participants to smell household odorants.

24 Feb 2021

Mucosal delivery of IFNs a good strategy for COVID-19 prophylaxis post-exposure

Researchers from the UK and Germany recently reported a comprehensive characterization of the SARS-CoV-2 response of human nasal epithelial cells, revealing a response dominated by IFN-I/IIIs. Also, recombinant IFN-I/III treatment was found to efficiently block the replication of SARS-CoV-2, which suggests that mucosal delivery of IFNs may be a good strategy for prophylaxis post-exposure.

22 Feb 2021

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.

18 Feb 2021

Researchers develop protocols for rapid serological surveys of SARS-CoV-2 infection

A new study by researchers from Emory and Yale Universities in the USA discusses a design for quickly launching serological surveys to assess the prevalence of this infection in a given population.

15 Feb 2021

Smell and taste loss symptoms associated with robust SARS-CoV-2 antibody response in new study

Researchers in Italy report a correlation between the loss of smell and taste and an observed persistence or rise in antibody levels at five months after infection.

9 Feb 2021

Over 100 million in India may have been infected by SARS-CoV-2

A large new study posted on the preprint server medRxiv describes the seropositivity rate to this virus, as well as the persistence of antibodies over time, both neutralizing and others.

19 Jan 2021

Can transgenic mice studies illuminate neurological complications associated with SARS-CoV-2 in humans?

The potentially deadly COVID-19 has not affected animals with corresponding severity. To understand the mechanism of severe disease, animal models have been used. This includes a mouse model that expresses human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2). A new study indicates that this may not be a faithful model of human lethal infection with SARS-CoV-2.

18 Jan 2021

Treating post-infectious smell loss in COVID-19 patients

News-Medical catches up with Professor Carl Philpott about the latest findings regarding COVID-19 and smell loss.

18 Jan 2021

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.

6 Jan 2021

One-third of COVID-19 survivors manifest neurological problems

In a longitudinal study recently published on the preprint server medRxiv*, Andrea Pilotto et al. find that one-third of COVID-19 infection survivors have long-term neurological manifestations after hospitalization.

5 Jan 2021

Loss of taste and smell may be most reliable COVID-19 symptoms for digital surveillance

A team of researchers from various institutions in London, Israel, and the USA recently tested the existence of consistent links between COVID-19 symptoms and SARS-CoV-2 test status in 3 national surveillance platforms.

24 Dec 2020

High seroprevalence of short-lived anti-SARS-CoV-2 antibodies in Paris

A recent study indicates a high seroprevalence of antibodies against SARS-CoV-2 among individuals working in a Paris-based institute.

3 Dec 2020

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) and also of milder disease, including loss of the sense of smell, according to a recent University of Iowa study published in Nature.

1 Dec 2020

Which dietary supplements can help prevent COVID-19?

Researchers explore dietary supplement usage during the COVID-19 pandemic.

1 Dec 2020

Altered smell and taste impacts psychological wellbeing of COVID-19 survivors, study finds

A recent study discloses that loss of taste and smell sensation after infection with SARS-CoV-2 negatively impacts the quality of life and psychological wellbeing of those that recover but experience persistence of this symptom.

1 Dec 2020

Anosmia News and Research

Researchers conduct large meta-analysis of COVID-19’s neurological manifestations

Researchers examine long-term immune responses following COVID-19 across clinically diverse cohort

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

Study finds link between Googling symptoms and COVID-19 cases

Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain

Household odorant smell tests could help detect COVID-19, say study

Mucosal delivery of IFNs a good strategy for COVID-19 prophylaxis post-exposure

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Researchers develop protocols for rapid serological surveys of SARS-CoV-2 infection

Smell and taste loss symptoms associated with robust SARS-CoV-2 antibody response in new study

Over 100 million in India may have been infected by SARS-CoV-2

Can transgenic mice studies illuminate neurological complications associated with SARS-CoV-2 in humans?

Treating post-infectious smell loss in COVID-19 patients

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

One-third of COVID-19 survivors manifest neurological problems

Loss of taste and smell may be most reliable COVID-19 symptoms for digital surveillance

High seroprevalence of short-lived anti-SARS-CoV-2 antibodies in Paris

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

Which dietary supplements can help prevent COVID-19?

Altered smell and taste impacts psychological wellbeing of COVID-19 survivors, study finds

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News